Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies.

被引：0

作者：

Domingo, Enric ^{[1
]}

Rathee, Sanjay ^{[1
]}

Blake, Andrew ^{[1
]}

Samuel, Leslie M. ^{[2
]}

Murray, Graeme I. ^{[3
]}

Sebag-Montefiore, David ^{[4
]}

Gollins, Simon ^{[5
]}

West, Nicholas ^{[4
]}

Begum, Rubina ^{[6
]}

Duggan, Marian ^{[6
]}

White, Laura ^{[6
]}

Richman, Susan ^{[4
]}

Quirke, Philip ^{[4
]}

Robineau, James ^{[1
]}

Redmond, Keara ^{[7
]}

Chatzipli, Aikaterini ^{[8
]}

McDermott, Ultan ^{[8
]}

Tomlinson, Ian ^{[9
]}

Dunne, Philip ^{[7
]}

Buffa, Francesca ^{[1
]}

Maughan, Tim ^{[1
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Aberdeen Royal Infirm, Aberdeen, Scotland

[3] Univ Aberdeen, Aberdeen, Scotland

[4] Univ Leeds, Leeds, W Yorkshire, England

[5] North Wales Canc Treatment Ctr, Bodelwyddan, Wales

[6] UCL, London, England

[7] Queens Univ Belfast, Belfast, Antrim, North Ireland

[8] Wellcome Trust Sanger Inst, Cambridge, England

[9] Univ Edinburgh, Edinburgh, Midlothian, Scotland

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB129

引用

页数：1

共 22 条

[1] Preoperative radiotherapy with concomitant fluoropyrimidine-based chemotherapy for resectable locally advanced rectal cancer
Atasoy, Beste Melek
Dane, Faysal
Caglar, Hale
Tezcanli, Evrim
Cingi, Asim
Abacioglu, Ufuk
Turhal, Serdar
Yegen, Cumhur
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (04): : 163 - 171
[2] Insights from prospective multi-omic profiling of lymphocytes in resected lung cancer
Chow, A.
Hellmann, M. D.
ANNALS OF ONCOLOGY, 2022, 33 (01) : 4 - 5
[3] Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
Yan, Yilv
Sun, Dongqing
Hu, Junjie
Chen, Yue
Sun, Liangdong
Yu, Huansha
Xiong, Yicheng
Huang, Zhida
Xia, Haoran
Zhu, Xinsheng
Bian, Dongliang
Sun, Fenghuan
Hou, Likun
Wu, Chunyan
Fan, Orion R.
Hu, Haiyang
Zeng, An
Zhang, Lele
Sun, Yi Eve
Wang, Chenfei
Zhang, Peng
NATURE GENETICS, 2025, 57 (01) : 126 - 139
[4] Akkermansia muciniphila- based multi-omic profiling in advanced non-small cell lung cancer
Belluomini, L.
Bonato, A.
Almonte, A.
Gattazzo, F.
Lebhar, I.
Birebent, R.
Flament, C.
Xiberras, M.
Marques, M.
Ly, P.
Thelemaque, C.
Parisi, C.
Masip, J. Remon
Besse, B.
Planchard, D.
Silva, C. Alves Costa
Barlesi, F.
Zitvogel, L.
Derosa, L.
ANNALS OF ONCOLOGY, 2024, 35 : S762 - S762
[5] A novel workflow for isolation and multi-omic profiling of DCCs derived from cerebrospinal fluid of patients with pediatric brain cancer
Czyz, Zbigniew T.
Feliciello, Giancarlo
Guzvic, Miodrag
Schamberger, Thomas
Grunewald, Sandra
Corbacioglu, Selim
Riemenschneider, Markus J.
Polzer, Bernhard
Klein, Christoph A.
CANCER RESEARCH, 2019, 79 (13)
[6] Prediction model of the response of neoadjuvant chemotherapy and long term survival according to multi-omic profiling in cooperation with clinicopathologic features in patients with breast cancer
Kim, Ji-Yeon
Park, Kyunghee
Park, Woong-Yang
Lee, Jeong Eon
Kim, Seok Won
Nam, Seok Jin
Lee, Se Kyung
Kan, Zhengyan
Park, Yeon Hee
CANCER RESEARCH, 2022, 82 (04)
[7] Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fluoropyrimidine-based chemotherapy: Evidence from 24 studies
Qiu, Li-Xin
Tang, Qi-Yun
Bai, Jian-Ling
Qian, Xiao-Ping
Li, Ru-Tian
Liu, Bao-Rui
Zheng, Ming-Hua
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) : 2384 - 2389
[8] Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials
Bujko, K.
Glynne-Jones, R.
Bujko, M.
ANNALS OF ONCOLOGY, 2010, 21 (09) : 1743 - 1750
[9] Benefit of fluoropyrimidine based adjuvant chemotherapy in rectal cancer according to its pathological response: Results from an observational study.
Herrera, MaryTere
Caderillo-Ruiz, German
Diaz, Consuelo
Ruiz Garcia, Erika B.
Zuratzi Deneken, Connie
Ruiz, Abraham
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[10] DOES POSTOPERATIVE ADJUVANT FLUOROPYRIMIDINE-BASED CHEMOTHERAPY PROVIDE A BENEFIT FOR PATIENTS WITH RESECTABLE RECTAL CANCER WHO HAVE ALREADY RECEIVED NEOADJUVANT RADIO(CHEMO)THERAPY? A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Bujko, K.
Glynne-Jones, R.
Bujko, M.
ANNALS OF ONCOLOGY, 2010, 21 : I41 - I41

← 1 2 3 →